论文部分内容阅读
目的:探讨宫血宁对上环术后月经过多的防治效果,为我矿医院提高上环术水平提供重要的参考依据。方法:抽取我院2012年1月份到2013年10月份收治的104例行上环术治疗的患者作为研究对象,并结合其临床资料随机分为对照组和观察组,每组52例,其中对照组术后不用药治疗;观察组术后给予宫血宁胶囊口服,连续治疗3个月后对两组患者的临床防治月经过多效果进行分析和比较。结果:经治疗后发现,在术后1、2和3个月的月经量方面,观察组明显要少于对照组,比较差异有显著统计学意义(P<0.01);另外在术后1、2和3个月的血红蛋白量方面,观察组则要高于对照组,比较差异同样具有显著统计学意义(P<0.01)。结论:临床给予上环术后患者宫血宁治疗,能够有效防治术后月经过多的情况,具有较高的临床应用价值,值得进一步推广应用。
Objective: To explore the effect of Gongxuening on the prevention and treatment of postmenopausal menorrhagia and to provide an important reference for improving the level of the circumcision in our mine hospital. Methods: A total of 104 patients treated with cycloplegia in our hospital from January 2012 to October 2013 were selected as the study subjects, and randomly divided into control group and observation group according to their clinical data. Each group included 52 patients The patients in the observation group were treated with Gongxuening capsule orally after operation for 3 months and the clinical effects of prevention and treatment of menorrhagia in the two groups were analyzed and compared. Results: After treatment, the observation group was significantly less than the control group in 1, 2 and 3 months of postoperative menstrual flow, the difference was statistically significant (P <0.01); In addition, after 1, 2 and 3 months hemoglobin, the observation group was higher than the control group, the difference was also statistically significant (P <0.01). Conclusion: Clinical application of Gongxuening therapy in patients with postoperative supra-annular surgery can effectively prevent and treat postmenopausal menorrhagia, which has high clinical value and is worth further promotion and application.